As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: May 31, 2012
by News Medical:
NT-MDT S&L (Ireland) is working in collaboration with the University of Limerick (UL) and a number of other Universities across Europe to develop an instrument, which will be capable of screening patients cells for Alzheimer’s disease.
The University of Limerick scientists have been awarded €5.4 million from the European Community’s Seventh Framework Programme to develop the device and will lead the European team.
NT-MDT will provide key input into the project and will develop a detection complex from prototype stage through to a commercial table-top device. The project will be called LANIR (Label Free Nanoscopy Using Infra-Red).
Currently there are 7.7 million new cases of dementia each year worldwide, implying that there is a new case of dementia somewhere in the world every four seconds. At present there is no test to screen for this disease. The World Alzheimer Report 2011 identified that the current lack of detection is a significant barrier to improving lives of people with Alzheimer’s disease.
The instrument, which will be developed by NT-MDT and its partners, will allow direct imaging of the structure of very small features – as small as 70 nanometers in lateral dimension, which is comparable to the size of a virus.
The LANIR device will be based on infrared spectroscopy. The technique is capable of seeing buried features without the need for destroying the surface of a cell or a material.
NT-MDT S&L (Ireland) welcome the collaboration; “This project is a good example of the strength of UL in transnational research where research strongly impacts the industrial community. UL and NT-MDT’s ability to work closely together, both in terms of R&D and geographic proximity, will be extremely helpful in implementing and commercializing the breakthrough technology from LANIR into a robust product.”
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
Foods can determine whether someone will suffer from dementia in later years, according to researchers at the Hebrew University of Jerusalem’s Faculty of Agriculture, Food and Environment in Rehovot. A large-scale international study that...
Taking care of someone with Alzheimer’s disease and other forms of dementia is not an easy task. Caregiving is a long-term endeavour that is mentally, emotionally, physically, and financially demanding, and is a role that...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.